Literature DB >> 369300

Changes in learning, memory, and mood during lithium treatment. Approach to a research strategy.

D Kropf, B Müller-Oerlinghausen.   

Abstract

In a double-blind study the effects of a 14-day lithium medication (dosage: 24 mval/day to 36 mval/day) were investigated. The subjects were 24 healthy male volunteers. The effect of lithium on their mood, ability to learn nouns, and memory of the words learnt was measured after 2 hours and 14 days. In spite of a relatively low mean plasma lithium level on the 14th day (0.54 +/- 0.15 mmol/l), the lithium volunteers assessed themselves after 2 weeks of treatment as significantly less relaxed, less active, less socially involved, more bored, and more tired than the placebo group. As to learning, the lithium group showed only a slight impairment of performance compared with the placebo groups. As to memory, there was a significant difference in free recall over 2 weeks: the lithium group remembered fewer words than the placebo group. Additional motivation of free recall over 2 hours was ineffective. It is discussed whether lithium changes spontaneous initial action and thereby the will to act. This could be interpreted as a change in the production of the characteristics of experience and behaviour.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 369300     DOI: 10.1111/j.1600-0447.1979.tb06951.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  10 in total

Review 1.  [Anti-suicidal effect of lithium: current state of research and its clinical implications for the long-term treatment of affective disorders].

Authors:  U Lewitzka; M Bauer; W Felber; B Müller-Oerlinghausen
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

Review 2.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

3.  Cognitive effects of lithium treatment in normal volunteers.

Authors:  H Weingartner; M V Rudorfer; M Linnoila
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Clinical pharmacology of a new antidepressant, Y-8894 in healthy young and elderly volunteers.

Authors:  C Ogura; A Kishimoto; N Kunimoto; F Omura; M Matsubayashi; T Tsutsui; M Shimizu
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

Review 5.  Lithium and cognitive enhancement: leave it or take it?

Authors:  Eleftheria Tsaltas; Dimitris Kontis; Vasileios Boulougouris; George N Papadimitriou
Journal:  Psychopharmacology (Berl)       Date:  2008-09-10       Impact factor: 4.530

Review 6.  The effects of lithium on cognition: an updated review.

Authors:  Arlin K Pachet; Amy M Wisniewski
Journal:  Psychopharmacology (Berl)       Date:  2003-09-19       Impact factor: 4.530

Review 7.  The behavioral actions of lithium in rodent models: leads to develop novel therapeutics.

Authors:  Kelley C O'Donnell; Todd D Gould
Journal:  Neurosci Biobehav Rev       Date:  2007-04-13       Impact factor: 8.989

8.  Lithium ions inhibit function of low- but not high-affinity muscarinic receptors of murine neuroblastoma cells (clone N1E-115).

Authors:  S Kanba; M Pfenning; E Richelson
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  The neurocognitive functioning in bipolar disorder: a systematic review of data.

Authors:  Eirini Tsitsipa; Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2015-12-01       Impact factor: 3.455

10.  Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications.

Authors:  Alejandro Szmulewicz; Cecilia Samamé; Pablo Caravotta; Diego J Martino; Ana Igoa; Diego Hidalgo-Mazzei; Francesc Colom; Sergio A Strejilevich
Journal:  Int J Bipolar Disord       Date:  2016-02-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.